2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide

C14H17N5O3 — CID 166329274

IUPAC2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide
SMILESCNC(=O)Cc1ccccc1NC(=O)Nc1[nH]ncc1OC
InChIInChI=1S/C14H17N5O3/c1-15-12(20)7-9-5-3-4-6-10(9)17-14(21)18-13-11(22-2)8-16-19-13/h3-6,8H,7H2,1-2H3,(H,15,20)(H3,16,17,18,19,21)
InChIKeyIHPYEOSJARUXOP-UHFFFAOYSA-N
MW303.32 g/mol
LogP1.35
Rot. Bonds5

About 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide

2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide (PubChem CID 166329274) has the molecular formula C14H17N5O3 and a molecular weight of 303.32 g/mol. Its IUPAC name is 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide.

Molecular Properties

Compound Name2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide
PubChem CID166329274
Molecular FormulaC14H17N5O3
Molecular Weight303.32 g/mol
Exact Mass303.13
IUPAC Name2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide
SMILESCNC(=O)Cc1ccccc1NC(=O)Nc1[nH]ncc1OC
InChIInChI=1S/C14H17N5O3/c1-15-12(20)7-9-5-3-4-6-10(9)17-14(21)18-13-11(22-2)8-16-19-13/h3-6,8H,7H2,1-2H3,(H,15,20)(H3,16,17,18,19,21)
InChIKeyIHPYEOSJARUXOP-UHFFFAOYSA-N
XLogP1.35
TPSA108.14 Ų
H-Bond Donors4
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500303.32
LogP ≤ 51.35
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 104

Analyze 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-(4-ethyl-1H-pyrazol-5-yl)-3-(2-methoxyphenyl)urea
CID 104620572
N-(4-ethyl-1H-pyrazol-5-yl)-2-(2-methoxyphenyl)acetamide
CID 112697113
2-[2-[[2-hydroxyethyl-[(2-methoxyphenyl)methyl]carbamoyl]amino]phenyl]-N-methylacetamide
CID 55819269
4-amino-N-[2-[2-(methylamino)-2-oxoethyl]phenyl]butanamide
CID 43704976
N-methyl-2-[2-[(4-methylphenyl)methylcarbamoylamino]phenyl]acetamide
CID 47033746
N-methyl-2-[2-(3-methylbutan-2-ylamino)phenyl]acetamide
CID 43692244
4-chloro-N-[2-[2-(methylamino)-2-oxoethyl]phenyl]butanamide
CID 63307585
3-amino-2-methyl-N-[2-[2-(methylamino)-2-oxoethyl]phenyl]propanamide
CID 55105612
6-bromo-N-[2-[2-(methylamino)-2-oxoethyl]phenyl]pyridine-3-carboxamide
CID 66462324
1-[2-(methoxymethyl)phenyl]-3-methylurea
CID 115582115
1-[4-(imidazol-1-ylmethyl)phenyl]-3-(4-methoxy-1H-pyrazol-5-yl)urea
CID 155962944
N-(1H-indazol-6-yl)-2-(2-methoxyphenyl)acetamide
CID 36559497

Frequently Asked Questions

What is the IUPAC name of 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide?
The IUPAC name of 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide (CID 166329274) is 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide.
What is the SMILES notation for 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide?
The canonical SMILES for 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide is CNC(=O)Cc1ccccc1NC(=O)Nc1[nH]ncc1OC.
What is the InChIKey of 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide?
The InChIKey is IHPYEOSJARUXOP-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H17N5O3/c1-15-12(20)7-9-5-3-4-6-10(9)17-14(21)18-13-11(22-2)8-16-19-13/h3-6,8H,7H2,1-2H3,(H,15,20)(H3,16,17,18,19,21).
What are the key properties of 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide?
2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide has a molecular weight of 303.32 g/mol, XLogP of 1.35, 5 rotatable bonds, 4 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[(4-methoxy-1H-pyrazol-5-yl)carbamoylamino]phenyl]-N-methylacetamide is sourced from PubChem (CID 166329274), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).